The estimated Net Worth of Deborah Woo is at least $94.6 mil dollars as of 8 September 2016. Deborah Woo owns over 1,176 units of Usana Health Sciences Inc stock worth over $94,579 and over the last 15 years Deborah sold USNA stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Deborah Woo USNA stock SEC Form 4 insiders trading
Deborah has made over 24 trades of the Usana Health Sciences Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently Deborah exercised 1,176 units of USNA stock worth $67,761 on 8 September 2016.
The largest trade Deborah's ever made was exercising 14,279 units of Usana Health Sciences Inc stock on 8 May 2015 worth over $506,476. On average, Deborah trades about 3,463 units every 61 days since 2010. As of 8 September 2016 Deborah still owns at least 2,537 units of Usana Health Sciences Inc stock.
You can see the complete history of Deborah Woo stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Deborah Woo's mailing address?
Deborah's mailing address filed with the SEC is 3838 WEST PARKWAY BLVD., , SALT LAKE CITY, UT, 84120.
Insiders trading at Usana Health Sciences Inc
Over the last 28 years, insiders at Usana Health Sciences Inc have traded over $838,318,381 worth of Usana Health Sciences Inc stock and bought 4,600 units worth $120,973 . The most active insiders traders include Myron W Wentz, Global Ltd Gull y Myron W Gull Global Ltd Wentz. On average, Usana Health Sciences Inc executives and independent directors trade stock every 7 days with the average trade being worth of $572,994. The most recent stock trade was executed by Paul A. Jones on 13 August 2024, trading 6,266 units of USNA stock currently worth $240,489.
What does Usana Health Sciences Inc do?
usana health sciences’ mission is to develop and provide the highest quality, science-based health products, distributed internationally through network marketing, creating a rewarding financial opportunity for our independent associates, shareholders, and employees. we’ve got history. not baggage. we’ve been around since 1992, so we’re experienced (we’ve heard that’s a plus). and we look great for our age. plus, we have substance to go along with our great looks. we’ve got top-notch manufacturing facilities, our own scientists and research and development team, and the highest standards for our nutritional products. we have an award-winning compensation plan and award-winning products. we don’t like to brag, but we come pretty highly recommended. that’s because we got off on the right foot. we were founded by a scientist—not a corporate suit. usana’s founder, myron wentz, is an internationally recognized microbiologist, immunologist, and pioneer in infectious disease diagnosis. but su
What does Usana Health Sciences Inc's logo look like?
Complete history of Deborah Woo stock trades at Usana Health Sciences Inc
Usana Health Sciences Inc executives and stock owners
Usana Health Sciences Inc executives and other stock owners filed with the SEC include:
-
Kevin Guest,
Chairman of the Board, Chief Executive Officer -
Jim Brown,
President -
Kevin G. Guest,
Chairman & CEO -
G Hekking,
Chief Financial Officer -
David Mulham,
Chief Field Development Officer -
Walter Noot,
Chief Operating Officer -
Jim Brown,
Pres -
Daniel Macuga,
Chief Communications and Marketing Officer -
G. Douglas Hekking,
Chief Financial Officer -
David Mulham,
Chief Sales Officer -
Walter Noot,
Chief Operating Officer -
Paul Jones,
Chief Leadership Development Officer -
Peggie Pelosi,
Independent Director -
Gilbert Fuller,
Lead Independent Director -
Robert Anciaux,
Senior Director -
Frederic Winssinger,
Independent Director -
Feng Peng,
Independent Director -
Timothy Wood,
Independent Director -
Dr. Myron W. Wentz,
Founder & Chairman Emeritus -
John Fleming,
Director -
Brent Neidig,
Chief Officer and Managing Director of China -
P. Joshua Foukas,
Chief Legal Officer, General Counsel and Corporate Secretary -
Robert Sinnott,
Chief Scientific Officer -
P. Joshua Foukas,
Chief Legal Officer, Gen. Counsel & Corp. Sec. -
Patrique Richards,
Exec. Director of Investor Relations & Bus. Devel. -
Dr. John Cuomo,
Exec. Director of Product Devel. & Technology -
J Scott Nixon,
Director -
Myron W Gull Global Ltd Wentz,
-
Robert Auciaux,
-
Global Ltd Gull,
10% owner -
Myron W Wentz,
CEO -
Deborah Woo,
E.V.P. of Sales -
Donald R. Williams,
Director -
Dave Wentz,
President -
James Bramble,
-
Jerry G Mcclain,
Director -
Denis E Waitley,
Director -
Roy Truett,
Chief Information Officer -
Doug Braun,
Chief Marketing Officer -
Ronald S Poelman,
Director -
Rick Stambaugh,
Chief Information Officer -
Holdings Ltd Gull,
10% owner -
Fred W Cooper,
Vice President of Operations -
Jeffrey Yates,
Chief Financial Officer -
Mark H Wilson,
V.P. of Customer Relations -
Bradford Richardson,
E.V.P. of Asia Pacific -
G Doug Iiekking,
CHIEF FINANCIAL OFFICER -
Peter Benedict,
CHIEF INFORMATION OFFICER -
Joshua Foukas,
CHIEF LEGAL OFFICER -
Xia Ding,
Director